Trial Profile
A retrospective study evaluating time on treatment among patients treated with everolimus and chemotherapy in postmenopausal women with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Capecitabine
- Indications Breast cancer
- Focus Therapeutic Use
- 24 Oct 2016 New trial record